Abstract
A controversial stem cell treatment for neurodegenerative diseases, provided by the Stamina Foundation, is continuing on a small scale along with the trial.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献